Home/Stocks/RNAC

RNAC

USD

Cartesian Therapeutics Inc. Common Stock

$7.710-0.200 (-2.528%)

Real-time Price

Healthcare

Biotechnology

United States

Price Chart

Loading Chart...

Key Metrics

Market Metrics

Company Fundamentals

Trading Stats

Market Metrics

Open

$7.910

High

$8.160

Low

$7.675

Volume

0.31M

Company Fundamentals

Market Cap

200.5M

Industry

Biotechnology

Country

United States

Trading Stats

Avg Volume

0.09M

Exchange

NGM

Currency

USD

52-Week Range

Low $7.675Current $7.710High $26.5

Related News

Oct 30, 2025 · 11:05 AM

GlobeNewswire

Cartesian Therapeutics Announces New Employment Inducement Grants

FREDERICK, Md., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Cartesian Therapeutics, Inc. (NASDAQ:RNAC) (the "Company"), a clinical-stage biotechnology company pioneering cell therapy for autoimmune diseases, today announced the

Related Stocks

LAUR

Laureate Education Inc.

NASDAQ

Other Consumer ...

MSGE

Madison Square Garden Entertainment Corp.

NASDAQ

Services-Misc. ...

LQDT

Liquidity Services Inc.

NASDAQ

Business Servic...

CNC

Centene Corporation

SP500

Managed Health ...

PHT

Pioneer High Income Fund Inc.

NASDAQ

Investment Mana...

Stay Updated

Set price alerts, get AI analysis updates and real-time market news.